We are live on ! Find out more
FBT icon

First Trust NYSE Arca Biotechnology Index Fund
FBT

236 hedge funds and large institutions have $860M invested in First Trust NYSE Arca Biotechnology Index Fund in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 70 increasing their positions, 79 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 22

1% more funds holding

Funds holding: 233 → 236 (+3)

1.02% more ownership

Funds ownership: 46.07% → 47.09% (+1%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

5% less capital invested

Capital invested by funds: $908M → $860M (-$47.4M)

11% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 79

Holders
236
Holders Change
+3
Holders Change %
+1.29%
% of All Funds
4.13%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
28
Increased
70
Reduced
79
Closed
22
Calls
$1.81M
Puts
–
Net Calls
+$1.81M
Net Calls Change
+$999K

Top Buyers

Rank Fund Capital Flow
1
KCM
Karp Capital Management
California
+$11.1M
2
AIC
Ameritas Investment Company
Nebraska
+$6.63M
3
QAM
Q3 Asset Management
Michigan
+$5.96M
4
AA
Ancora Advisors
Ohio
+$3.61M
5
HI
Harbour Investments
Wisconsin
+$3.15M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$19.2M
2
Wells Fargo
Wells Fargo
California
-$7.19M
3
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$5.16M
4
LPL Financial
LPL Financial
California
-$4.41M
5
RJA
Raymond James & Associates
Florida
-$3.31M
Name Holding Trade Value Shares
Change 		Change in
Stake
CWA
226
Clearview Wealth Advisors
Oregon
$7K – – –
HI
227
Hoey Investments
Pennsylvania
$5K – – –
HI
228
Hudock Inc
Pennsylvania
$5K – – –
CCA
229
Column Capital Advisors
Indiana
$4K – – –
VRM
230
Vectors Research Management
New York
$3K +$2.9K +17 New
FMP
231
Financial Management Professionals
Texas
$2K – – –
FRA
232
Front Row Advisors
California
$2K – – –
WQ
233
Wealth Quarterback
New Jersey
$2K – – –
GFPC
234
Global Financial Private Client
Florida
$1.82K – – –
WIM
235
Westside Investment Management
California
$16 – – –
TCM
236
Triumph Capital Management
Colorado
– -$204K -6,878 Closed
SWP
237
Stratos Wealth Partners
Ohio
– -$893K -5,174 Closed
LFAS
238
Level Four Advisory Services
Texas
– -$572K -3,313 Closed
MAP
239
Milestone Advisory Partners
North Carolina
– -$337K -1,950 Closed
Creative Planning
240
Creative Planning
Kansas
– -$319K -1,850 Closed
EPA
241
Element Pointe Advisors
Florida
– -$275K -1,636 Closed
1WM
242
1900 Wealth Management
Texas
– -$274K -1,587 Closed
WI
243
Wintrust Investments
Illinois
– -$234K -1,353 Closed
WBG
244
Wharton Business Group
Pennsylvania
– -$207K -1,200 Closed
TWM
245
Triton Wealth Management
Arizona
– -$200K -1,173 Closed
WLIM
246
White Lighthouse Investment Management
Massachusetts
– -$201K -1,165 Closed
SB
247
Strategic Blueprint
Georgia
– -$164K -951 Closed
PGWM
248
Parisi Gray Wealth Management
New Jersey
– -$112K -650 Closed
ASN
249
Advisory Services Network
Georgia
– -$95K -552 Closed
TI
250
tru Independence
Oregon
– -$71K -414 Closed
7 8 9
10
11

FBT Hedge Fund Activity: Q3 2021 in Review

236 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2021, worth a combined $860M — down 5.2% from $908M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new FBT positions and 22 closed out — a net gain of 6 holders — while 70 added to existing stakes and 79 trimmed.

The largest buyer was Karp Capital Management, opening a new position worth an estimated $11.1M. The largest seller was Morgan Stanley, cutting an estimated $19.2M.

  • 236 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2021, up from 233 in Q2 2021.
  • Funds reported $860M of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2021, down 5.2% quarter-over-quarter.
  • 28 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2021 and 22 closed out, a net change of +6 holders.
  • The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2021 was Karp Capital Management, an estimated $11.1M added.
  • The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2021 was Morgan Stanley, an estimated $19.2M sold.

Based on aggregated 13F filings for Q3 2021.